Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
Nat Med
.
2022 May;28(5):1095-1096.
doi: 10.1038/s41591-022-01817-z.
Authors
Allison August
1
,
Husain Z Attarwala
2
,
Sunny Himansu
2
,
Shiva Kalidindi
2
,
Sophia Lu
2
,
Rolando Pajon
2
,
Shu Han
2
,
Jean-Michel Lecerf
2
,
Joanne E Tomassini
2
,
Marjie Hard
2
,
Leon M Ptaszek
3
,
James E Crowe
4
,
Tal Zaks
2
Affiliations
1
Moderna, Inc., Cambridge, MA, USA. Allison.august@modernatx.com.
2
Moderna, Inc., Cambridge, MA, USA.
3
Massachusetts General Hospital, Boston, MA, USA.
4
Vanderbilt University Medical Center, Nashville, TN, USA.
PMID:
35449420
PMCID:
PMC9117134
DOI:
10.1038/s41591-022-01817-z
No abstract available
Publication types
Published Erratum